SCHEMBL5659434

SCHEMBL5659434

COc1cccc(N2C(=O)C(c3ccc(O)c(C)c3)(c3cc(C)c(O)c(C)c3)c3ccccc32)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.42
MEN1 O00255 4/20 0.42
KMT2A Q03164 4/20 0.42
LMNA P02545 2/20 0.42
XBP1 P17861 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
ESR1 P03372 1/20 0.42
ESR2 Q92731 1/20 0.42
MGLL Q99685 1/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
POLB P06746 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
SCN9A Q15858 1/20 0.37
ALDH1A1 P00352 3/20 0.36
KDM4E B2RXH2 1/20 0.36
HSP90AA1 P07900 1/20 0.36
HSP90AB1 P08238 1/20 0.36
CNR1 P21554 1/20 0.35
GPR55 Q9Y2T6 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5656731 0.94 MAPT (0.41) MAPTMEN1KMT2ALMNAXBP1
SCHEMBL5656443 0.94 MAPT (0.44) MAPTMEN1KMT2AMGLLSMN1; SMN2
SCHEMBL5661100 0.92 MAPT (0.41) MAPTMEN1KMT2AMGLLSMN1; SMN2
SCHEMBL5658510 0.91 CNR1 (0.46) MAPTMEN1KMT2AMGLLSMN1; SMN2
SCHEMBL5662112 0.91 MAPT (0.41) MAPTMEN1KMT2AMGLLSMN1; SMN2
SCHEMBL5660840 0.90 MAPT (0.38) MAPTMEN1KMT2AMGLLSMN1; SMN2
SCHEMBL5661921 0.90 MAPT (0.41) MAPTMEN1KMT2AMGLLSMN1; SMN2
SCHEMBL5658916 0.89 MAPT (0.40) MAPTMEN1KMT2AMGLLSMN1; SMN2
SCHEMBL5658788 0.88 MAPT (0.38) MAPTMEN1KMT2AMGLLSMN1; SMN2
SCHEMBL5661171 0.88 ADAMTS5 (0.39) MAPTMEN1KMT2AMGLLSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7250442-B2 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators ELI LILLY AND COMPANY (US) 2007-07-31 US disclosed
US-7250442-B2 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators ELI LILLY AND COMPANY (US) 2007-07-31 US disclosed
US-7250442-B2 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators ELI LILLY AND COMPANY (US) 2007-07-31 US disclosed
US-20050054712-A1 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators ELI LILLY AND COMPANY 2005-03-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050054712-A1 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators NR3C2, NR5A1, NR5A2 MAPT 3588/4885MEN1 2928/4885KMT2A 3891/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.